Main > HEPATOLOGY > Hepatitis C Virus Infection > Treatment > Co: USA. G. Sofosbuvir+Velpatasvir+

---

Co: USA. G. Sofosbuvir+Velpatasvir+'s subsections
(*) EU Approval Date: 2017. 07.28
(*) USA Approval Date: 2017. 07.18
+Voxilaprevir
Company
TradeMark

Co: USA. G. Sofosbuvir+Velpatasvir+'s products
This section has no products